Stock BDX BECTON, DICKINSON AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-03 pm EDT 		5-day change 1st Jan Change
234.7 USD -2.36% Intraday chart for Becton, Dickinson and Company +1.35% -3.75%
May. 03 TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 MT
May. 02 Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280 MT

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 68,288 67,447 70,597 63,550 75,002 67,824 - -
Enterprise Value (EV) 1 87,112 82,533 85,924 78,609 89,465 80,454 78,183 75,538
P/E ratio 65 x 85.9 x 35.9 x 37.9 x 52.3 x 32.2 x 29.2 x 25.5 x
Yield 1.22% 1.36% 1.35% 1.56% - 1.6% 1.64% 1.73%
Capitalization / Revenue 3.95 x 3.94 x 3.49 x 3.37 x 3.87 x 3.35 x 3.17 x 3 x
EV / Revenue 5.04 x 4.82 x 4.24 x 4.17 x 4.62 x 3.98 x 3.65 x 3.34 x
EV / EBITDA 17 x 17.2 x 14.7 x 15.2 x 13.1 x 14.1 x 12.5 x 11.2 x
EV / FCF 36.7 x 30.2 x 25.2 x 52.5 x 42.3 x 27.5 x 20.8 x 18.4 x
FCF Yield 2.72% 3.31% 3.98% 1.91% 2.37% 3.64% 4.8% 5.44%
Price to Book 3.24 x 2.87 x 2.95 x 3.21 x - 2.58 x 2.48 x 2.36 x
Nbr of stocks (in thousands) 269,954 289,869 287,190 285,195 290,109 289,006 - -
Reference price 2 253.0 232.7 245.8 222.8 258.5 234.7 234.7 234.7
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 17,290 17,117 20,248 18,870 19,372 20,233 21,428 22,622
EBITDA 1 5,126 4,792 5,838 5,160 6,846 5,699 6,261 6,716
EBIT 1 4,372 3,994 4,971 4,362 4,558 4,883 5,317 5,753
Operating Margin 25.29% 23.33% 24.55% 23.12% 23.53% 24.14% 24.81% 25.43%
Earnings before Tax (EBT) 1 1,163 985 2,242 1,783 1,662 2,614 2,869 3,224
Net income 1 1,069 767 2,002 1,689 1,424 2,119 2,479 2,808
Net margin 6.18% 4.48% 9.89% 8.95% 7.35% 10.47% 11.57% 12.41%
EPS 2 3.890 2.710 6.850 5.880 4.940 7.290 8.042 9.190
Free Cash Flow 1 2,373 2,729 3,416 1,498 2,116 2,929 3,754 4,108
FCF margin 13.72% 15.94% 16.87% 7.94% 10.92% 14.48% 17.52% 18.16%
FCF Conversion (EBITDA) 46.29% 56.95% 58.51% 29.03% 30.91% 51.4% 59.96% 61.17%
FCF Conversion (Net income) 221.98% 355.8% 170.63% 88.69% 148.6% 138.21% 151.45% 146.31%
Dividend per Share 2 3.080 3.160 3.320 3.480 - 3.754 3.841 4.065
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 4,995 5,011 4,641 4,761 4,586 4,821 4,878 5,087 4,706 5,045 5,076 5,402 5,006 5,316 5,356
EBITDA 1 1,467 1,362 1,189 1,344 1,469 1,293 1,316 1,928 1,113 1,416 1,445 1,676 1,385 1,514 1,410
EBIT 1 1,274 1,161 1,009 1,121 1,264 1,077 1,107 1,341 914 1,207 1,253 1,459 1,144 1,287 1,335
Operating Margin 25.51% 23.17% 21.74% 23.55% 27.56% 22.34% 22.69% 26.36% 19.42% 23.92% 24.68% 27.01% 22.84% 24.21% 24.93%
Earnings before Tax (EBT) 1 723 525 421 321 481 529 471 181 359 633 709 914 579 772 823
Net income 1 655 431 338 265 486 438 392 108 281 537 568.6 750 507.3 626.5 696
Net margin 13.11% 8.6% 7.28% 5.57% 10.6% 9.09% 8.04% 2.12% 5.97% 10.64% 11.2% 13.88% 10.13% 11.78% 12.99%
EPS 2 2.280 1.500 1.180 0.9200 1.700 1.530 1.360 0.3700 0.9600 1.850 1.840 2.490 1.810 2.070 -
Dividend per Share 0.8700 - - - - - - - - - - - - - -
Announcement Date 2/3/22 5/5/22 8/4/22 11/10/22 2/2/23 5/4/23 8/3/23 11/9/23 2/1/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 18,824 15,086 15,327 15,059 14,463 12,630 10,359 7,714
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.672 x 3.148 x 2.625 x 2.918 x 2.113 x 2.216 x 1.684 x 1.149 x
Free Cash Flow 1 2,373 2,729 3,416 1,498 2,116 2,994 4,122 4,108
ROE (net income / shareholders' equity) 15.2% 12.8% 16.1% 6.9% 5.58% 14.4% 15.2% 15.8%
ROA (Net income/ Total Assets) 6.07% 6.19% 7.08% 3.16% 2.69% 7.28% 6.44% 7.06%
Assets 1 17,619 12,392 28,265 53,400 52,856 29,099 38,497 39,747
Book Value Per Share 2 78.00 81.10 83.20 69.30 - 91.10 94.60 99.50
Cash Flow per Share 2 12.10 12.50 15.90 8.600 10.40 18.60 23.00 -
Capex 1 957 810 1,231 973 874 900 946 982
Capex / Sales 5.53% 4.73% 6.08% 5.16% 4.51% 4.45% 4.41% 4.34%
Announcement Date 11/5/19 11/5/20 11/4/21 11/10/22 11/9/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
234.7 USD
Average target price
278.3 USD
Spread / Average Target
+18.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.82B
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.03% 25.03B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. Financials Becton, Dickinson and Company